Amarin Corporation plc (AMRN)

0,9112 -0,0074 (-0,81%) Ab 10:44AM EDT. Markt geöffnet.

Amarin Corporation plc

Iconic Offices, The Greenway
Block C Ardilaun Court St Stephens Green
Dublin 112-114
Ireland
353 0 166 99020
https://www.amarincorp.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - General
Vollzeitmitarbeiter: 275

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Patrick J. Holt	President, CEO & Director	678,88k	N/A	1973
Mr. Thomas Charles Reilly	Executive VP, CFO & Global Head of HR	1,01M	N/A	1973
Dr. Steven B. Ketchum Ph.D.	Executive VP, President of Research & Development and Chief Scientific Officer	1,16M	N/A	1965
Mr. Jonathan N. Provoost	Executive VP, Chief Legal & Compliance Officer and Secretary	160,08k	N/A	1970
Mr. Aaron D. Berg	Executive VP & President of U.S.	1,26M	N/A	1963
Mr. Jordan Zwick	Senior VP of Corporate Business Development & Investor Relations	N/A	N/A	1987
Mr. Laurent Abuaf	President of Europe & Senior VP	N/A	N/A	N/A
Dr. Nabil Abadir	Chief Medical Officer of Global Medical Affairs	N/A	N/A	N/A
Dr. David Keenan Ph.D.	Executive VP of Technical Operations & President of Europe	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.